ELFNX
Price
$97.46
Change
-$0.32 (-0.33%)
Updated
Aug 15 closing price
Net Assets
4.6B
VTSAX
Price
$154.04
Change
-$0.41 (-0.27%)
Updated
Aug 15 closing price
Net Assets
1.91T
Interact to see
Advertisement

ELFNX vs VTSAX

Header iconELFNX vs VTSAX Comparison
Open Charts ELFNX vs VTSAXBanner chart's image
Elfun Trusts
Price$97.46
Change-$0.32 (-0.33%)
VolumeN/A
Net Assets4.6B
Vanguard Total Stock Mkt Idx Adm
Price$154.04
Change-$0.41 (-0.27%)
VolumeN/A
Net Assets1.91T
ELFNX vs VTSAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ELFNX vs. VTSAX commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELFNX is a Buy and VTSAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.91T vs. ELFNX (4.6B). VTSAX pays higher dividends than ELFNX: VTSAX (1.18) vs ELFNX (0.85). ELFNX was incepted earlier than VTSAX: ELFNX (90 years) vs VTSAX (25 years). ELFNX (0.17) is less costly to investors than VTSAX (0.04). ELFNX is a more actively managed with annual turnover of: 25.00 vs. VTSAX (2.00). ELFNX has a lower initial minimum investment than VTSAX: ELFNX (500) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 16.53 vs. ELFNX (5.80). VTSAX return over 5 years is better than : 86.35 vs. ELFNX (48.44).
ELFNXVTSAXELFNX / VTSAX
Total Expense Ratio0.170.04425%
Annual Report Gross Expense Ratio0.170.04425%
Fund Existence90 years25 years-
Gain YTD10.8629.566114%
Front LoadN/AN/A-
Min. Initial Investment500300017%
Min. Initial Investment IRAN/AN/A-
Net Assets4.6B1.91T0%
Annual Yield % from dividends0.851.1871%
Returns for 1 year5.8016.5335%
Returns for 3 years39.3847.2183%
Returns for 5 years48.4486.3556%
Returns for 10 years75.00203.9837%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTGN3.310.36
+12.01%
VistaGen Therapeutics
RXRX5.770.13
+2.30%
Recursion Pharmaceuticals
FTV48.160.36
+0.75%
Fortive Corp
DSS0.83N/A
+0.39%
DSS
CBNK32.68-0.32
-0.97%
Capital Bancorp